431 related articles for article (PubMed ID: 32377532)
1. Dexmedetomidine Preconditioning Protects Rats from Renal Ischemia-Reperfusion Injury Accompanied with Biphasic Changes of Nuclear Factor-Kappa B Signaling.
Bao N; Tang B; Wang J
J Immunol Res; 2020; 2020():3230490. PubMed ID: 32377532
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine Preconditioning Ameliorates Inflammation and Blood-Spinal Cord Barrier Damage After Spinal Cord Ischemia-Reperfusion Injury by Down-Regulation High Mobility Group Box 1-Toll-Like Receptor 4-Nuclear Factor κB Signaling Pathway.
Liu J; Zhang S; Fan X; Yuan F; Dai J; Hu J
Spine (Phila Pa 1976); 2019 Jan; 44(2):E74-E81. PubMed ID: 29975331
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine Protects Rat Liver against Ischemia-Reperfusion Injury Partly by the α2A-Adrenoceptor Subtype and the Mechanism Is Associated with the TLR4/NF-κB Pathway.
Wang Y; Wu S; Yu X; Zhou S; Ge M; Chi X; Cai J
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347929
[TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine protects against lung injury induced by limb ischemia-reperfusion via the TLR4/MyD88/NF-κB pathway.
Xue BB; Chen BH; Tang YN; Weng CW; Lin LN
Kaohsiung J Med Sci; 2019 Nov; 35(11):672-678. PubMed ID: 31373750
[TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine preconditioning may attenuate myocardial ischemia/reperfusion injury by down-regulating the HMGB1-TLR4-MyD88-NF-кB signaling pathway.
Zhang JJ; Peng K; Zhang J; Meng XW; Ji FH
PLoS One; 2017; 12(2):e0172006. PubMed ID: 28222157
[TBL] [Abstract][Full Text] [Related]
6. Effect of dexmedetomidine on kidney injury in sepsis rats through TLR4/MyD88/NF-κB/iNOS signaling pathway.
Jin YH; Li ZT; Chen H; Jiang XQ; Zhang YY; Wu F
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):5020-5025. PubMed ID: 31210339
[TBL] [Abstract][Full Text] [Related]
7. Dexmedetomidine Inhibits TLR4/NF-κB Activation and Reduces Acute Kidney Injury after Orthotopic Autologous Liver Transplantation in Rats.
Yao H; Chi X; Jin Y; Wang Y; Huang P; Wu S; Xia Z; Cai J
Sci Rep; 2015 Nov; 5():16849. PubMed ID: 26585410
[TBL] [Abstract][Full Text] [Related]
8. Dexmedetomidine Resists Intestinal Ischemia-Reperfusion Injury by Inhibiting TLR4/MyD88/NF-κB Signaling.
Yang J; Wu Y; Xu Y; Jia J; Xi W; Deng H; Tu W
J Surg Res; 2021 Apr; 260():350-358. PubMed ID: 33383282
[TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine protects against cisplatin-induced acute kidney injury in mice through regulating apoptosis and inflammation.
Liang H; Liu HZ; Wang HB; Zhong JY; Yang CX; Zhang B
Inflamm Res; 2017 May; 66(5):399-411. PubMed ID: 28224201
[TBL] [Abstract][Full Text] [Related]
10. α2-Adrenoceptor agonist dexmedetomidine protects septic acute kidney injury through increasing BMP-7 and inhibiting HDAC2 and HDAC5.
Hsing CH; Lin CF; So E; Sun DP; Chen TC; Li CF; Yeh CH
Am J Physiol Renal Physiol; 2012 Nov; 303(10):F1443-53. PubMed ID: 22933299
[TBL] [Abstract][Full Text] [Related]
11. Dexmedetomidine preconditioning for myocardial protection in ischaemia-reperfusion injury in rats by downregulation of the high mobility group box 1-toll-like receptor 4-nuclear factor κB signalling pathway.
Yang YF; Peng K; Liu H; Meng XW; Zhang JJ; Ji FH
Clin Exp Pharmacol Physiol; 2017 Mar; 44(3):353-361. PubMed ID: 27998004
[TBL] [Abstract][Full Text] [Related]
12. Dexmedetomidine protects against lipopolysaccharide-induced early acute kidney injury by inhibiting the iNOS/NO signaling pathway in rats.
Chen Y; Luan L; Wang C; Song M; Zhao Y; Yao Y; Yang H; Ma B; Fan H
Nitric Oxide; 2019 Apr; 85():1-9. PubMed ID: 30659917
[TBL] [Abstract][Full Text] [Related]
13. Dexmedetomidine ameliorates acute lung injury following orthotopic autologous liver transplantation in rats probably by inhibiting Toll-like receptor 4-nuclear factor kappa B signaling.
Chi X; Wei X; Gao W; Guan J; Yu X; Wang Y; Li X; Cai J
J Transl Med; 2015 Jun; 13():190. PubMed ID: 26070954
[TBL] [Abstract][Full Text] [Related]
14. Osthole Preconditioning Protects Rats Against Renal Ischemia-Reperfusion Injury.
Xie DQ; Sun GY; Zhang XG; Gan H
Transplant Proc; 2015; 47(6):1620-6. PubMed ID: 26293024
[TBL] [Abstract][Full Text] [Related]
15. Dexmedetomidine Post-Conditioning Alleviates Cerebral Ischemia-Reperfusion Injury in Rats by Inhibiting High Mobility Group Protein B1 Group (HMGB1)/Toll-Like Receptor 4 (TLR4)/Nuclear Factor kappa B (NF-κB) Signaling Pathway.
Zhai Y; Zhu Y; Liu J; Xie K; Yu J; Yu L; Deng H
Med Sci Monit; 2020 Jan; 26():e918617. PubMed ID: 31912804
[TBL] [Abstract][Full Text] [Related]
16. The effect of dexmedetomidine against oxidative and tubular damage induced by renal ischemia reperfusion in rats.
Cakir M; Polat A; Tekin S; Vardi N; Taslidere E; Rumeysa Duran Z; Tanbek K
Ren Fail; 2015 May; 37(4):704-8. PubMed ID: 25687385
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol preconditioning protects hepatocytes against hepatic ischemia reperfusion injury via Toll-like receptor 4/nuclear factor-κB signaling pathway in vitro and in vivo.
He D; Guo Z; Pu JL; Zheng DF; Wei XF; Liu R; Tang CY; Wu ZJ
Int Immunopharmacol; 2016 Jun; 35():201-209. PubMed ID: 27064547
[TBL] [Abstract][Full Text] [Related]
18. Dexmedetomidine restores septic renal function via promoting inflammation resolution in a rat sepsis model.
Qiu R; Yao W; Ji H; Yuan D; Gao X; Sha W; Wang F; Huang P; Hei Z
Life Sci; 2018 Jul; 204():1-8. PubMed ID: 29733849
[TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine alleviates lipopolysaccharide-induced acute kidney injury by inhibiting the NLRP3 inflammasome activation via regulating the TLR4/NOX4/NF-κB pathway.
Yao Y; Hu X; Feng X; Zhao Y; Song M; Wang C; Fan H
J Cell Biochem; 2019 Oct; 120(10):18509-18523. PubMed ID: 31243816
[TBL] [Abstract][Full Text] [Related]
20. Dexmedetomidine preconditioning inhibits the long term inflammation induced by renal ischemia/reperfusion injury in rats.
Liu G; Song H; Qiu L; He A; Tong F; Wan Q; Wang X; Xia Y; Huang L
Acta Cir Bras; 2016 Jan; 31(1):8-14. PubMed ID: 26840350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]